£12.0M
The financing was co-led by Illumina Ventures and Mérieux Equity Partners to support the development and commercialisation of the company gene editing safety technology.
Broken String Biosciences
Genomics company building a platform to drive the development of safer cell and gene therapies.
£12.0MTotal raised
Broken String Biosciences is a genomics company building a proprietary platform to map DNA breaks and enhance the safety of cell and gene therapies. Headquartered in Cambridge, the firm works to accelerate the clinical development of gene editing programmes.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from Broken String Biosciences's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
FD
Felix Dobbs
Chief Executive Officer
Felix serves as co-founder and chief operating officer at Broken String Biosciences, having previously held the chief executive role at the same company.
LinkedIn